Neurocrine agrees to pay up to $1.7bn in gene therapy collaboration

[Farooqji]

Neurocrine and Voyager enter an agreement to fund and develop gene therapy candidates for the treatment of severe neurological diseases.

biopharma-reporter.com/Arti...

[danfitz]

A very big bet.

[Farooqji in reply to danfitz]

they have taken calculated risk. they may have carried out risk analysis before throwing money into it

[park_bear in reply to danfitz]

The headline number includes the maximum of potential payments under the agreement. The actual cash investment at this time is less than 10% of that.